drugset / Trial / NCT01007929
Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male Subjects
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to characterise the metabolism, excretion and pharmacokinetics of a single oral dose of \[14C\] AZD1236 in healthy male subjects.
Timeline
- Start
- 2009-10
- Primary completion
- —
- Completion
- 2009-11
Outcome
Outcome not reported
Stopped: “Future development of AZD1236 is currently under review by the project team and no new studies will be started until this review is completed.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD1236 | Small molecule | 60 mg | Oral |
Indications
No indication recorded.